EP1963522A4 - Mehrwertige von meningokokken stammende polysaccharid-protein-konjugate und vakzine - Google Patents
Mehrwertige von meningokokken stammende polysaccharid-protein-konjugate und vakzineInfo
- Publication number
- EP1963522A4 EP1963522A4 EP05858729A EP05858729A EP1963522A4 EP 1963522 A4 EP1963522 A4 EP 1963522A4 EP 05858729 A EP05858729 A EP 05858729A EP 05858729 A EP05858729 A EP 05858729A EP 1963522 A4 EP1963522 A4 EP 1963522A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- vaccine
- protein conjugates
- derivatized polysaccharide
- multivalent meningococcal
- meningococcal derivatized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2005/046886 WO2007102797A2 (en) | 2005-12-22 | 2005-12-22 | Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1963522A2 EP1963522A2 (de) | 2008-09-03 |
EP1963522A4 true EP1963522A4 (de) | 2010-05-12 |
Family
ID=38475284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05858729A Withdrawn EP1963522A4 (de) | 2005-12-22 | 2005-12-22 | Mehrwertige von meningokokken stammende polysaccharid-protein-konjugate und vakzine |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1963522A4 (de) |
JP (1) | JP2009521434A (de) |
CN (1) | CN101443454A (de) |
BR (1) | BRPI0516372A (de) |
MX (1) | MX2007007790A (de) |
WO (1) | WO2007102797A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102327605B (zh) * | 2011-08-25 | 2013-01-30 | 成都康华生物制品有限公司 | 四价脑膜炎球菌多糖疫苗的制备工艺 |
CN102809656B (zh) * | 2012-08-26 | 2014-09-03 | 云南沃森生物技术股份有限公司 | 一种脑膜炎球菌多糖结合疫苗成品各群游离多糖含量的测定方法 |
ES2672045T3 (es) * | 2014-07-25 | 2018-06-12 | Biosynth S.R.L. | Vacunas de productos glicoconjugados que comprenden unidades básicas de una construcción molecular que expresa múltiples epítopos incorporados para la formulación de una vacuna de amplio espectro contra infecciones debidas a bacterias enteropatógenas |
CN104383532A (zh) * | 2014-12-02 | 2015-03-04 | 云南沃森生物技术股份有限公司 | 一种用乙肝表面抗原为载体蛋白的细菌多糖蛋白结合物疫苗及其制备方法 |
CA3033364A1 (en) | 2016-09-02 | 2018-03-08 | Sanofi Pasteur, Inc. | Neisseria meningitidis vaccine |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998058670A1 (en) * | 1997-06-24 | 1998-12-30 | Chiron Corporation | Methods of immunizing adults using anti-meningococcal vaccine compositions |
WO2005004909A2 (en) * | 2003-05-07 | 2005-01-20 | Aventis Pasteur, Inc. | Method of enhanced immunogenicity to meningococcal vaccination |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5425946A (en) * | 1992-08-31 | 1995-06-20 | North American Vaccine, Inc. | Vaccines against group C Neisseria meningitidis |
-
2005
- 2005-12-22 JP JP2008547192A patent/JP2009521434A/ja active Pending
- 2005-12-22 CN CNA2005800486574A patent/CN101443454A/zh active Pending
- 2005-12-22 EP EP05858729A patent/EP1963522A4/de not_active Withdrawn
- 2005-12-22 BR BRPI0516372-2A patent/BRPI0516372A/pt not_active IP Right Cessation
- 2005-12-22 WO PCT/US2005/046886 patent/WO2007102797A2/en active Application Filing
- 2005-12-22 MX MX2007007790A patent/MX2007007790A/es unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998058670A1 (en) * | 1997-06-24 | 1998-12-30 | Chiron Corporation | Methods of immunizing adults using anti-meningococcal vaccine compositions |
WO2005004909A2 (en) * | 2003-05-07 | 2005-01-20 | Aventis Pasteur, Inc. | Method of enhanced immunogenicity to meningococcal vaccination |
Also Published As
Publication number | Publication date |
---|---|
JP2009521434A (ja) | 2009-06-04 |
WO2007102797A2 (en) | 2007-09-13 |
MX2007007790A (es) | 2009-06-05 |
WO2007102797A3 (en) | 2009-04-16 |
EP1963522A2 (de) | 2008-09-03 |
BRPI0516372A (pt) | 2008-09-02 |
CN101443454A (zh) | 2009-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL184154A0 (en) | Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine | |
HK1257962A1 (zh) | 多價肺炎球菌多糖-蛋白質綴合物組合物 | |
HRP20190037T1 (hr) | Cjepivo na bazi konjugata pneumokoknih polisaharida | |
HK1204574A1 (en) | Multivalent meningococcal derivatized polysaccharide protein conjugates and corresponding vaccines | |
IL181951A0 (en) | Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine | |
ZA200904331B (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
ZA200904619B (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
IL181551A0 (en) | Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine | |
EP1963522A4 (de) | Mehrwertige von meningokokken stammende polysaccharid-protein-konjugate und vakzine | |
IL181228A0 (en) | Vlp-antigen conjugates and their uses as vaccines | |
ZA200708542B (en) | Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine | |
AU2007203489A1 (en) | Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine | |
ZA200805347B (en) | Pneumococcal polysaccharide conjugate vaccine | |
ZA200701667B (en) | VLP-antigen conjugates and their use as vaccines | |
ZA200805409B (en) | Vaccine comprising streptococcus pneumoniae capsular polyaccharide conjugates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20070723 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK YU |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: RYALL, ROBERT, P. |
|
R17D | Deferred search report published (corrected) |
Effective date: 20090416 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 39/095 20060101ALI20090429BHEP Ipc: A61K 39/02 20060101AFI20090429BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20100414 |
|
17Q | First examination report despatched |
Effective date: 20101202 |
|
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20140701 |